Position in GLMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31
-$45 QoQ
Shares Held
56
-64.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 13 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,934,888 across 523 Biotechnology names. GLMD ranks #500 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in GLMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31 | 56 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $76 | 157 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $223 | 298 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $135 | 98 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $61,774 | 33,573 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $10,634 | 7,385 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $39,970 | 12,530 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $713 | 104 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $9,958 | 36,213 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $5,016 | 14,498 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $37,522 | 82,468 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $12,419 | 20,032 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $37,368 | 12,498 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $87,212 | 204,245 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $90,362 | 180,724 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $58,971 | 189,620 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $127,204 | 195,699 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $262,827 | 165,300 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $292,656 | 160,800 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $458,955 | 164,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $559,968 | 184,200 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $636,443 | 185,552 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $504,914 | 162,352 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $459,481 | 130,165 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $529,159 | 110,703 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $268,329 | 77,552 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||